NCT06918431
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06918431
Title Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors City of Hope Medical Center
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope at Phoenix RECRUITING Phoenix Arizona 85338 United States Details
City of Hope Medical Center RECRUITING Duarte California 91010 United States Details
City of Hope at Irvine Lennar NOT_YET_RECRUITING Irvine California 92618 United States Details
UC San Diego Moores Cancer Center NOT_YET_RECRUITING La Jolla California 92093 United States Details
UCLA / Jonsson Comprehensive Cancer Center NOT_YET_RECRUITING Los Angeles California 90095 United States Details
University of Chicago Comprehensive Cancer Center NOT_YET_RECRUITING Chicago Illinois 60637 United States Details
Memorial Sloan Kettering Cancer Center NOT_YET_RECRUITING New York New York 10065 United States Details
Cleveland Clinic Foundation NOT_YET_RECRUITING Cleveland Ohio 44195 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field